drugset / Trial / NCT00619073

PACT (Platelet Activity After Clopidogrel Termination)

NCT00619073

RandomizedCrossoverQuadruple-blindBasic science

Summary

Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots. The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting risk. However, this theory has never been rigorously tested. The goal of this research is to determine whether discontinuation of clopidogrel results in increased platelet function.

Timeline

Start
2008-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg Oral
Comparator Aspirin Small molecule 81 mg Oral